Ohyashiki J - Search Results

1

Identification of a novel role of Septin 10 in paclitaxel-resistance in cancers through a functional genomics screen.

Xu M, Takanashi M, Oikawa K, Nishi H, Isaka K, Yoshimoto T, Ohyashiki J, Kuroda M. Xu M, et al. Among authors: ohyashiki j. Cancer Sci. 2012 Apr;103(4):821-7. doi: 10.1111/j.1349-7006.2012.02221.x. Epub 2012 Mar 4. Cancer Sci. 2012. PMID: 22320903 Free PMC article.

2

Comparison of telomerase activity in normal chorionic villi to trophoblastic diseases.

Nishi H, Yahata N, Ohyashiki K, Isaka K, Shiraishi K, Ohyashiki JH, Toyama K, Takayama M. Nishi H, et al. Among authors: ohyashiki k, ohyashiki jh. Int J Oncol. 1998 Jan;12(1):81-5. doi: 10.3892/ijo.12.1.81. Int J Oncol. 1998. PMID: 9454890

3

Expression of telomerase subunits and localization of telomerase activation in hydatidiform mole.

Nishi H, Ohyashiki K, Fujito A, Yahata N, Ohyashiki JH, Isaka K, Takayama M. Nishi H, et al. Among authors: ohyashiki k, ohyashiki jh. Placenta. 1999 May;20(4):317-23. doi: 10.1053/plac.1998.0386. Placenta. 1999. PMID: 10329353

4

Turnover of acinar and islet cells in the pancreas of monosodium glutamate-treated obese mice.

Nakayama D, Magami Y, Azuma T, Inokuchi H, Furukawa M, Ohyashiki J, Yoshimoto T, Mizuguchi J, Moriyasu F, Kawai K, Hattori T. Nakayama D, et al. Among authors: ohyashiki j. Obes Res. 2003 Jan;11(1):87-94. doi: 10.1038/oby.2003.14. Obes Res. 2003. PMID: 12529490 Free article.

5

Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients.

Tanaka M, Oikawa K, Takanashi M, Kudo M, Ohyashiki J, Ohyashiki K, Kuroda M. Tanaka M, et al. Among authors: ohyashiki j, ohyashiki k. PLoS One. 2009;4(5):e5532. doi: 10.1371/journal.pone.0005532. Epub 2009 May 14. PLoS One. 2009. PMID: 19440243 Free PMC article.

6

Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a.

Ohyashiki JH, Umezu T, Kobayashi C, Hamamura RS, Tanaka M, Kuroda M, Ohyashiki K. Ohyashiki JH, et al. BMC Res Notes. 2010 Dec 24;3:347. doi: 10.1186/1756-0500-3-347. BMC Res Notes. 2010. PMID: 21182798 Free PMC article.

7

Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma.

Ohyashiki K, Umezu T, Yoshizawa S, Ito Y, Ohyashiki M, Kawashima H, Tanaka M, Kuroda M, Ohyashiki JH. Ohyashiki K, et al. PLoS One. 2011 Feb 24;6(2):e16408. doi: 10.1371/journal.pone.0016408. PLoS One. 2011. PMID: 21383985 Free PMC article.

8

Leukemia cell to endothelial cell communication via exosomal miRNAs.

Umezu T, Ohyashiki K, Kuroda M, Ohyashiki JH. Umezu T, et al. Among authors: ohyashiki k, ohyashiki jh. Oncogene. 2013 May 30;32(22):2747-55. doi: 10.1038/onc.2012.295. Epub 2012 Jul 16. Oncogene. 2013. PMID: 22797057

9

Sustained upregulation of effector natural killer cells in chronic myeloid leukemia after discontinuation of imatinib.

Mizoguchi I, Yoshimoto T, Katagiri S, Mizuguchi J, Tauchi T, Kimura Y, Inokuchi K, Ohyashiki JH, Ohyashiki K. Mizoguchi I, et al. Among authors: ohyashiki k, ohyashiki jh. Cancer Sci. 2013 Sep;104(9):1146-53. doi: 10.1111/cas.12216. Epub 2013 Jul 9. Cancer Sci. 2013. PMID: 23758044 Free PMC article.

10

Immunosurveillance markers may predict patients who can discontinue imatinib therapy without relapse.

Yoshimoto T, Mizoguchi I, Katagiri S, Tauchi T, Furusawa JI, Chiba Y, Mizuguchi J, Ohyashiki JH, Ohyashiki K. Yoshimoto T, et al. Among authors: ohyashiki k, ohyashiki jh. Oncoimmunology. 2014 May 14;3:e28861. doi: 10.4161/onci.28861. eCollection 2014. Oncoimmunology. 2014. PMID: 25057448 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters